Supply Of Medicines_req

Give

Tenders

The Institute invites Two Cover Tenders from Class I and II local suppliers, as per DPIIT order No. P-45021/2/2017-PP (BE-II) dated 04 Jun 2020, for the following items through the eProcurement System of National Informatics Centre that enables the Tenderers to download the Tender Schedule free of cost and then submit the bids online through Central Public Procurement Portal of Government of India (https://eprocure.gov.in/eprocure/app). Please quote only in Indian Rupees as per GFR 2017 amended Rule 161 (iv) and Public Procurement (Preference to make in India) order 2017, with your lowest rate and shortest delivery period as per the following terms.

SL No	Description of Goods
1	Supply of Medicines as per Annexure 6, item wise L1 will be awarded. Tenders are to be uploaded in two cover.
2	Important points to be complied by bidders/suppliers are as under:
a)	The suppliers should have a regd office/warehouse/shop within 40 KM radius.
b)	The supply should be in line with the directives of Ministry of Chemicals & Fertilizers Department of Pharmaceuticals Government of India issued vide order no. F. No. 3 10261 4120 1 B-Policy dated 14.01.2019.
c)	The medicines procured under Public Procurement from 1^st April 2019 must have Bar code/QR Code at primary level packaging. Such Code will mandatorily contain Name of the product including strength, brand name (if there is any), MRP, name & address of Manufacturer, Batch Number, Manufacturing date, expiry date, special storage conditions required (if any) and manufacturing license number.
d)	All medicines shall be supplied in the original, unopened, sealed and tamper-proof packaging of the manufacturer. The packaging and labelling shall comply with all applicable statutory requirements. Medicines supplied in damaged, broken, leaking, tampered or otherwise defective packaging shall be liable for rejection.
e)	The supplier shall ensure that the medicines are stored, handled and transported in accordance with the storage conditions prescribed by the manufacturer and applicable regulatory requirements. Medicines requiring temperature-controlled transportation shall be transported under appropriate temperature-controlled conditions.
f)	Unless otherwise specified in the Schedule of Requirements, the medicines supplied shall have a minimum residual shelf life of 75% of the total shelf life at the time of delivery. In exceptional cases where procurement of a particular medicine with shorter residual shelf life is unavoidable, the supplier shall obtain prior written approval from the Institute before dispatch.
g)	The Institute shall have the right to reject medicines which are found to be sub-standard, adulterated, spurious, damaged, improperly packed, expired, having inadequate residual shelf life, not conforming to the prescribed specifications, or otherwise unsuitable for use.
h)	The supplier shall, at its own cost and risk, collect and replace rejected/non-conforming medicines with conforming medicines within the period specified by the Institute. No additional payment shall be admissible for such replacement.
i)	The supplier shall comply with all applicable laws, rules, regulations and orders relating to the manufacture, storage, sale, transportation and supply of medicines, as per the prevailing rules and regulations.
j)	No change in the manufacturer, brand, composition, strength, dosage form or pack size of the approved medicine shall be permitted. Any unauthorized substitution shall be liable for rejection.
k)	The procurement shall be governed by the applicable provisions of the General Financial Rules (GFR), Manual for Procurement of Goods, 2024, orders/instructions issued by the Department of Pharmaceuticals, Department of Expenditure, DPIIT and other competent authorities, as applicable from time to time. In case of any conflict, the applicable statutory/Government provisions shall prevail.